Feasibility study of the existence of dual inhibitors of COX-2/DHODH based on virtual screening

被引：0
|
作者：
Li, Shunlai [1 ]
Li, Xiuyan [1 ]
Du, Hongguang [1 ]
机构：
[1] School of Science, Beijing University of Chemical Technology, Beijing 100029, China
来源：
Beijing Huagong Daxue Xuebao (Ziran Kexueban)/Journal of Beijing University of Chemical Technology (Natural Science Edition) | 2008年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 29
相关论文
共 50 条
  • [41] Antiproliferative Diarylpyrazole Derivatives as Dual Inhibitors of the ERK Pathway and COX-2
    El-Gamal, Mohammed I.
    Choi, Hong Seok
    Yoo, Kyung Ho
    Baek, Daejin
    Oh, Chang-Hyun
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 82 (03) : 336 - 347
  • [42] QSAR Classification-Based Virtual Screening Followed by Molecular Docking Identification of Potential COX-2 Inhibitors in a Natural Product Library
    Ai, Shangjie
    Lin, Guanfei
    Bai, Yong
    Liu, Xiande
    Piao, Linghua
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2019, 26 (11) : 1296 - 1315
  • [43] Dual-target inhibitors based on COX-2: a review from medicinal chemistry perspectives
    Zhang, Fengmei
    Zhu, Guonian
    Li, Yangqian
    Qi, Yawen
    Wang, Zhoufeng
    Li, Weimin
    FUTURE MEDICINAL CHEMISTRY, 2023, 15 (23) : 2209 - 2233
  • [44] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
    Debabrata Mukherjee
    Eric J Topol
    Arthritis Res Ther, 5
  • [45] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Luo, C
    He, ML
    Bohlin, L
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) : 926 - 933
  • [46] COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors
    Whittle, BJR
    GUT, 2000, 47 (03) : 320 - 325
  • [47] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Cheng Luo
    Ming-liang He
    Lars Bohlin
    Acta Pharmacologica Sinica, 2005, 26 : 926 - 933
  • [48] Cox-2 selective inhibitors induce apoptosis by both cox-2 dependent and cox-2 independent mechanisms.
    Agarwal, B
    Swaroop, P
    Protiva, P
    Chuttani, R
    Ramey, WG
    Holt, PR
    GASTROENTEROLOGY, 2000, 118 (04) : A52 - A52
  • [49] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitors
    Graham, Kamara Whitney
    Sevigny, Mary B.
    Gabriel, Bianca S.
    FASEB JOURNAL, 2009, 23
  • [50] COX-2 inhibitors and gastrointestinal toxicity
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 164 (08) : 1200 - 1200
12345